Valuation: Sartorius Stedim Biotech

Capitalization 19.04B 20.71B 18.32B 16.03B 29.81B 1,801B 32.79B 210B 79.62B 759B 77.63B 76.06B 3,071B P/E ratio 2025 *
61.5x
P/E ratio 2026 * 46x
Enterprise value 21.21B 23.07B 20.41B 17.86B 33.21B 2,006B 36.53B 234B 88.7B 846B 86.49B 84.74B 3,422B EV / Sales 2025 *
7x
EV / Sales 2026 * 6.19x
Free-Float
30.28%
Yield 2025 *
0.37%
Yield 2026 * 0.47%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.98%
1 week+1.32%
Current month-1.68%
1 month-7.27%
3 months+0.80%
6 months+5.87%
Current year+3.68%
More quotes
1 week
184.45
Extreme 184.45
195.65
1 month
184.45
Extreme 184.45
195.65
Current year
179.7
Extreme 179.7
195.65
1 year
139.1
Extreme 139.1
195.65
3 years
139.1
Extreme 139.1
195.65
5 years
137.6
Extreme 137.6
195.65
10 years
30.62
Extreme 30.6167
195.65
More quotes
Manager TitleAgeSince
Chief Executive Officer 49 2023-03-27
Chief Tech/Sci/R&D Officer 60 2011-09-07
Investor Relations Contact 56 -
Director TitleAgeSince
Chairman 59 2007-06-28
Director/Board Member 63 2007-06-28
Director/Board Member 63 2015-04-06
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+0.98%+1.32%-28.20%-40.44% 20.71B
-2.45%-7.61%+9.72%+7.86% 220B
+0.80%-1.51%+11.37%-11.70% 119B
+1.43%-1.55%-4.53%-12.64% 64.89B
+0.80%+1.37%+8.33%+70.47% 50.04B
+1.08%+0.32%-9.22%+37.76% 40.32B
+3.23%-9.19%-45.81%-32.04% 27.62B
+1.10%+2.83%-3.01%+56.87% 27.42B
+1.88%-2.63%-1.49%+1.98% 22.27B
+2.23%+1.83%-12.14%-7.74% 21.89B
Average +1.11%-1.48%-7.50%+7.04% 61.43B
Weighted average by Cap. -0.06%-3.32%+1.65%+6.95%
See all sector performances

Financials

2025 *2026 *
Net sales 3.03B 3.3B 2.92B 2.55B 4.74B 287B 5.22B 33.43B 12.67B 121B 12.36B 12.11B 489B 3.39B 3.69B 3.26B 2.85B 5.31B 321B 5.84B 37.4B 14.18B 135B 13.82B 13.54B 547B
Net income 310M 337M 298M 261M 485M 29.31B 534M 3.42B 1.3B 12.36B 1.26B 1.24B 50B 421M 458M 405M 354M 659M 39.78B 724M 4.64B 1.76B 16.78B 1.72B 1.68B 67.85B
Net Debt 2.17B 2.36B 2.09B 1.83B 3.4B 206B 3.74B 23.97B 9.09B 86.68B 8.86B 8.68B 351B 1.96B 2.13B 1.88B 1.65B 3.07B 185B 3.37B 21.61B 8.19B 78.12B 7.99B 7.82B 316B
More financial data * Estimated data
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
9,901
More about the company
Date Price Change Volume
25-03-14 195.65 +0.98% 52,902
25-03-13 193.75 -0.54% 51,953
25-03-12 194.80 +4.73% 86,363
25-03-11 186.00 -1.20% 85,383
25-03-10 188.25 -2.51% 63,316

Real-time Euronext Paris, March 14, 2025 at 12:35 pm EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
195.65EUR
Average target price
248.00EUR
Spread / Average Target
+26.76%
Consensus

Quarterly revenue - Rate of surprise